Wells Fargo’s Acura Pharmaceuticals ACUR Stock Holding History

Wells Fargo’s Portfolio ACUR Stock Details ACUR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-2	Closed	–	–	6729
2016 Q4	$0	Hold	2	–	–	﹤0.01%	6635
2016 Q3	$0	Buy	+2	New	+$4	﹤0.01%	6515
2016 Q2	–	Sell	-360	Closed	-$1K	–	6562
2016 Q1	$1K	Buy	+360	New	+$765	﹤0.01%	6148
2015 Q1	–	Sell	-200	Closed	–	–	6536
2014 Q4	$0	Hold	200	–	–	﹤0.01%	6575
2014 Q3	$1K	Sell	200 -400	-67%	-$1.88K	﹤0.01%	6126
2014 Q2	$3K	Hold	600	–	–	﹤0.01%	5918
2014 Q1	$4K	Hold	600	–	–	﹤0.01%	5602
2013 Q4	$5K	Sell	600 -3,800	-86%	-$32.1K	﹤0.01%	5390
2013 Q3	$42K	Buy	4,400 +200	+5%	+$1.77K	﹤0.01%	4727
2013 Q2	$40K	Buy	+4,200	New	+$47.5K	﹤0.01%	4673

Other funds holding ACUR

EWM

Essex Woodlands Management The Woodlands, Texas $251M AUM 13.72% 1-Year Est. Return

Wells Fargo's ACUR Position: Q1 2017 in Review

Wells Fargo sold out of Acura Pharmaceuticals (ACUR) in Q1 2017, closing a stake of 2 shares.

Wells Fargo first reported a position in ACUR in Q2 2013 and held it in 10 quarters. The position peaked at $42K in Q3 2013. 3 funds tracked by Wall St. Rank hold ACUR as of Q1 2017.

Wells Fargo reported no remaining Acura Pharmaceuticals position as of Q1 2017 after selling out during the quarter.
Wells Fargo sold 2 Acura Pharmaceuticals shares in Q1 2017.
Wells Fargo first reported a position in Acura Pharmaceuticals in Q2 2013 and held it in 10 quarters.
Wells Fargo's Acura Pharmaceuticals position peaked at $42K in Q3 2013.
3 funds tracked by Wall St. Rank held Acura Pharmaceuticals as of Q1 2017.

Based on Wells Fargo's 13F filing for Q1 2017, filed 28 Apr 2017.